Cingulate (CING) EVP and CSO Raul Silva receives grant of 3,885 stock options

Rhea-AI Filing Summary

Cingulate Inc. reported that EVP and CSO Raul R. Silva received a grant of stock options as part of his compensation. The award covers options for 3,885 shares of common stock at an exercise price of $5.47 per share, expiring in 2036. These options were granted pursuant to Dr. Silva's employment agreement and increase his potential equity exposure but do not represent an open-market purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Silva Raul R.

Role EVP and CSO

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to Buy)	3,885	$0.00	--

Holdings After Transaction: Stock Option (right to Buy) — 3,885 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Options granted: 3,885 options Exercise price: $5.47 per share Expiration date: June 30, 2036 +3 more

6 metrics

Options granted 3,885 options Stock Option (right to buy) grant to EVP and CSO

Exercise price $5.47 per share Conversion or exercise price of option grant

Expiration date June 30, 2036 Option expiration date

Underlying shares 3,885 shares Common stock underlying the option grant

Holdings after grant 3,885 derivative securities Total options following this transaction

Transaction code A Grant, award, or other acquisition

Key Terms

Stock Option (right to Buy), Common Stock, Employment Agreement, Grant, award, or other acquisition

4 terms

Stock Option (right to Buy) financial

"security_title: "Stock Option (right to Buy)""

Common Stock financial

"underlying_security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Employment Agreement financial

"The option was granted pursuant to the terms of Dr. Silva's Employment Agreement"

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/02/2026 - 06:00 PM Accepted by SEC EDGAR 07/02/2026 - 06:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Silva Raul R.

(Last) (First) (Middle)

1901 W. 47TH PLACE

(Street)

KANSAS CITY KANSAS 66205

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cingulate Inc. [ CING ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and CSO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to Buy)	$5.47	06/30/2026(1)		A		3,885		06/30/2026	06/30/2036	Common Stock	3,885	$0	3,885	D

Explanation of Responses:

1. The option was granted pursuant to the terms of Dr. Silva's Employment Agreement, as amended.

	/s/ Raul Silva	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Cingulate (CING) EVP Raul R. Silva report in this Form 4?

Raul R. Silva reported receiving a grant of stock options for 3,885 shares. The options give him the right to buy Cingulate common stock as part of his compensation package, rather than reflecting an open-market trade.

How many Cingulate (CING) shares are covered by Dr. Silva’s new stock options?

The grant covers options on 3,885 shares of Cingulate common stock. These options are a derivative award that, if exercised, would allow him to purchase 3,885 shares at the specified exercise price.

What is the exercise price of Raul R. Silva’s Cingulate (CING) stock options?

The stock options have an exercise price of $5.47 per share. This is the fixed price at which Dr. Silva can buy Cingulate common stock if he chooses to exercise the options before they expire.

When do Raul R. Silva’s new Cingulate (CING) stock options expire?

The stock options are scheduled to expire on June 30, 2036. Dr. Silva can choose to exercise them any time before this expiration date, subject to the terms of his employment agreement and the option plan.

Is Raul R. Silva’s Form 4 transaction a market purchase or sale of Cingulate (CING) stock?

The Form 4 reflects a grant of stock options, not a market trade. It records a compensation-related acquisition of derivative securities, rather than an open-market buy or sell of Cingulate common stock.